344 related articles for article (PubMed ID: 24184674)
1. Encapsulation of immunoglobulin G by solid-in-oil-in-water: effect of process parameters on microsphere properties.
Marquette S; Peerboom C; Yates A; Denis L; Goole J; Amighi K
Eur J Pharm Biopharm; 2014 Apr; 86(3):393-403. PubMed ID: 24184674
[TBL] [Abstract][Full Text] [Related]
2. Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres.
Marquette S; Peerboom C; Yates A; Denis L; Langer I; Amighi K; Goole J
Int J Pharm; 2014 Aug; 470(1-2):41-50. PubMed ID: 24792974
[TBL] [Abstract][Full Text] [Related]
3. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
Hsu YY; Hao T; Hedley ML
J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
[TBL] [Abstract][Full Text] [Related]
4. Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres.
Wang J; Chua KM; Wang CH
J Colloid Interface Sci; 2004 Mar; 271(1):92-101. PubMed ID: 14757081
[TBL] [Abstract][Full Text] [Related]
5. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
Yang Y; Gao Y; Mei X
Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
[TBL] [Abstract][Full Text] [Related]
6. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
7. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
Xu Q; Crossley A; Czernuszka J
J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
Della Porta G; Reverchon E
Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
[TBL] [Abstract][Full Text] [Related]
10. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
11. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
[TBL] [Abstract][Full Text] [Related]
12. [Effect of NaCl in outer water phase on the characteristics of BSA-loaded PLGA sustained-release microspheres fabricated by a solid-in-oil-in-water emulsion technique].
Zhou XL; He JT; Zhou ZT; Ma SF; Jiang Y; Wang Y
Yao Xue Xue Bao; 2010 Aug; 45(8):1057-63. PubMed ID: 21351596
[TBL] [Abstract][Full Text] [Related]
13. Sustained release of low molecular weight heparin from PLGA microspheres prepared by a solid-in-oil-in-water emulsion method.
He J; Zhou Z; Fan Y; Zhou X; Du H
J Microencapsul; 2011; 28(8):763-70. PubMed ID: 22034953
[TBL] [Abstract][Full Text] [Related]
14. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
Ma G
J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
[TBL] [Abstract][Full Text] [Related]
15. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H
Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969
[TBL] [Abstract][Full Text] [Related]
16. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
17. Issues in long-term protein delivery using biodegradable microparticles.
Ye M; Kim S; Park K
J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
[TBL] [Abstract][Full Text] [Related]
18. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
19. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
Lane ME; Brennan FS; Corrigan OI
Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
[TBL] [Abstract][Full Text] [Related]
20. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.
Cleland JL; Jones AJ
Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
